Repsly and Curaleaf have entered into a new technology partnership that will provide data-driven insights as the company assesses its wholesale execution plans.
Technology platform Repsly will support Curaleaf‘s wholesale operations across the US by providing CRM solutions, retail execution support, and business analytics and insights to the Curaleaf teams.
Curaleaf has 125 dispensaries in 23 states across the US.
The company stated it chose Repsly after realising a need to enhance its technology stack in support of its rapidly expanding go-to-market needs within North America.
Read more: Curaleaf International launches for European cannabis market
Patrick Larkin, SVP of Sales at Curaleaf, commented: “With Repsly’s powerful operational platform and their Insights Dashboard business intelligence solution, we’ll be able to assess our wholesale execution plans with real-time and trended data on sales performance, promotion execution and more.
“These data-driven insights will allow our team to learn and pivot on a dime as feedback comes in from their field.”
CEO at Repsly, Matthew Brogie, commented: “Our team at Repsly is obsessed with helping our customers win by executing perfectly at all aspects of retail, every day.
“Knowing that we have the opportunity to help Curaleaf navigate competitively in one of the fastest-growing consumer industries, and that we can support Curaleaf and their portfolio of brands in their next-generation plans is extremely energising for our team.
“We’re looking forward to rolling up our sleeves and working hard to demonstrate that Repsly is the right partner to support Curaleaf in this amazing growth journey.”
Read more: Curaleaf International on the growth of the European cannabis market
“With Repsly’s powerful operational platform and their Insights Dashboard business intelligence solution, we’ll be able to assess our wholesale execution plans with real-time and trended data on sales performance, promotion execution and more. These data-driven insights will allow our team to learn and pivot on a dime as feedback comes in from their field,” said Patrick Larkin, SVP of Sales at Curaleaf.
Curaleaf, formerly EMMAC Life Sciences Group, will begin to roll out the Repsly platform in February 2022.
